ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
65 hedge funds and large institutions have $78.1M invested in Zynerba Pharmaceuticals, Inc in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 66 → 65 (-1)
Holders
65
Holding in Top 10
–
Calls
$4.21M
Puts
$2.11M
Top Buyers
| 1 | +$14M | |
| 2 | +$7.11M | |
| 3 | +$4.09M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.05M |
| 5 |
Millennium Management
New York
|
+$1.94M |
Top Sellers
| 1 | -$6.69M | |
| 2 | -$680K | |
| 3 | -$527K | |
| 4 |
Goldman Sachs
New York
|
-$308K |
| 5 |
Two Sigma Advisers
New York
|
-$208K |